[
  {
    "seedTrialID": "ST20182602A",
    "seedTrialTemplate": "complete",
    "clinicalTrialsDotGovXmlRequired": "true",
    "leadOrgTrialID": "UPCC 75605092 seed data",
    "clinicalTrialsDotGovTrialID": "NCT91914292",
    "otherTrialID": "818280292",
    "title": "A Phase I/II Study Of Brentuximab Vedotin In Combination With Multi-Agent Chemotherapy II",
    "phase": "I",
    "pilot": "false",
    "accrualDiseaseTerminology": "ICD10",
    "primaryPurpose": "Other",
    "primaryPurposeOtherDescription": "Determine maximum tolerated dose (MTD) of brentuximab vedotin",
    "interventionalDesign": null,
    "interventionalDesign_secondaryPurpose": "Other",
    "interventionalDesign_secondaryPurposeOtherDescription": "Secondary Other Description",
    "leadOrganization": null,
    "leadOrganization_existingOrganization": null,
    "leadOrganization_existingOrganization_poID": "181802",
    "pi": null,
    "pi_existingPerson": null,
    "pi_existingPerson_poID": "5000",
    "sponsor": null,
    "sponsor_existingOrganization": null,
    "sponsor_existingOrganization_poID": "181802",
    "responsibleParty": null,
    "responsibleParty_type": "Sponsor-Investigator",
    "responsibleParty_investigator": null,
    "responsibleParty_investigator_existingPerson": null,
    "responsibleParty_investigator_existingPerson_poID": "5000",
    "responsibleParty_investigatorTitle": "CEO &amp; Chairman",
    "summary4FundingSponsor": null,
    "summary4FundingSponsor_existingOrganization": null,
    "summary4FundingSponsor_existingOrganization_poID": "181802",
    "programCode": "PG00001",
    "fundedByNciGrant": "false",
    "grant": null,
    "grant_fundingMechanism": "B09",
    "grant_nihInstitutionCode": "AA",
    "grant_serialNumber": "111111",
    "grant_nciDivisionProgramCode": "CCR",
    "grant_fundingPercentage": "100",
    "trialStatus": "In Review",
    "whyStopped": null,
    "trialStatusDate": "2014-07-15",
    "trialStartDate": null,
    "trialStartDate_Actual": "2014-07-15",
    "trialStartDate_Anticipated": "X",
    "primaryCompletionDate": null,
    "primaryCompletionDate_Actual": "X",
    "primaryCompletionDate_Anticipated": "2019-07-15",
    "completionDate": null,
    "completionDate_Actual": "X",
    "completionDate_Anticipated": "2019-07-15",
    "ind": null,
    "ind_number": "111111",
    "ind_grantor": "CDER",
    "ind_holderType": "NIH",
    "ind_nihInstitution": "NEI",
    "ind_expandedAccess": "true",
    "ind_expandedAccessType": "Available",
    "ind_exempt": "true",
    "ide": null,
    "ide_number": "222222",
    "ide_grantor": "CDRH",
    "ide_holderType": "NCI",
    "ide_nciDivisionProgramCode": "CCR",
    "ide_expandedAccess": "true",
    "ide_expandedAccessType": "Available",
    "ide_exempt": "true",
    "regulatoryInformation": null,
    "regulatoryInformation_country": "USA",
    "regulatoryInformation_authorityName": "Federal Government",
    "regulatoryInformation_fdaRegulated": "true",
    "regulatoryInformation_section801": "true",
    "regulatoryInformation_delayedPosting": "true",
    "regulatoryInformation_dataMonitoringCommitteeAppointed": "true",
    "protocolDocument": "dGVzdA==",
    "protocolDocument_filename": "protocol.pdf",
    "irbApprovalDocument": "dGVzdA==",
    "irbApprovalDocument_filename": "irb.pdf",
    "participatingSitesDocument": "dGVzdA==",
    "participatingSitesDocument_filename": "sites.pdf",
    "informedConsentDocument": "dGVzdA==",
    "informedConsentDocument_filename": "consent.pdf",
    "otherDocument": "dGVzdA==",
    "otherDocument_filename": "other.pdf",
    "category": "Externally Peer-Reviewed",
    "trialOwner": "qatest@nih.gov"
  }
]
